Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Oncogene

• Publication date

  2007-02-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1209849PMID 16953231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane

  2005cited by this paper
• The p400 E1A-associated protein is a novel component of the p53 --> p21 senescence pathway.

  2005cited by this paper
• Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin.

  2005cited by this paper
• Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression

  2004cited by this paper
• Short hairpin activated gene silencing in mammalian cells.

  2004cited by this paper
• Activation of the tumor suppressor merlin modulates its interaction with lipid rafts.

  2004cited by this paper
• Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators

  2004influential reference
• RNA interference by short hairpin RNAs expressed in vertebrate cells.

  2004cited by this paper
• The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

  2004cited by this paper
• E-cadherin Negatively Regulates CD44-Hyaluronan Interaction and CD44-mediated Tumor Invasion and Branching Morphogenesis*

  2003influential reference
• NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.

  2003cited by this paper
• An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo

  2003cited by this paper
• Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.

  2003cited by this paper
• The role of the CD44/ezrin complex in cancer metastasis.

  2003cited by this paper
• Elevated Hyaluronan Production Induces Mesenchymal and Transformed Properties in Epithelial Cells*

  2003cited by this paper
• The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product.

  2002cited by this paper
• Structural Basis for Neurofibromatosis Type 2

  2002cited by this paper
• Angiopoietin-2 is implicated in the regulation of tumor angiogenesis.

  2001cited by this paper
• Metastasis-associated differences in gene expression in a murine model of osteosarcoma.

  2001cited by this paper
• Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway

  2001cited by this paper
• The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.

  2001cited by this paper
• The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

  2001influential reference
• Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.

  2000cited by this paper
• Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

  2000cited by this paper
• Conditional biallelic Nf 2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2

  2000cited by this paper
• Matrix metalloproteinases in tumor invasion and metastasis.

  2000influential reference
• Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations

  1999cited by this paper
• Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

  1999influential reference
• Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein.

  1999cited by this paper
• Analysis of CD 44-containing Lipid Rafts : Recruitment of Annexin II and Stabilization by the Actin Cytoskeleton

  1999cited by this paper
• Analysis of Cd44-Containing Lipid Rafts

  1999cited by this paper
• Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading.

  1999cited by this paper
• Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain

  1998influential reference
• Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane.

  1998influential reference
• Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors.

  1998cited by this paper
• NHE-RF, a Regulatory Cofactor for Na+-H+Exchange, Is a Common Interactor for Merlin and ERM (MERM) Proteins*

  1998cited by this paper
• Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.

  1998cited by this paper
• Ezrin/Radixin/Moesin (ERM) Proteins Bind to a Positively Charged Amino Acid Cluster in the Juxta-Membrane Cytoplasmic Domain of CD44, CD43, and ICAM-2

  1998cited by this paper
• Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells

  1998influential reference
• Structural Analysis of Drosophila Merlin Reveals Functional Domains Important for Growth Control and Subcellular Localization

  1998cited by this paper
• Neurofibromatosis 2 tumour suppressor schwannomin interacts with βII-spectrin

  1998cited by this paper
• Merlin, the neurofibromatosis type 2 gene product, and beta1 integrin associate in isolated and differentiating Schwann cells.

  1998cited by this paper
• Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas

  1997cited by this paper
• AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44

  1997cited by this paper
• Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.

  1997influential reference
• ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction.

  1997cited by this paper
• Induction of Apoptosis of Metastatic Mammary Carcinoma Cells In Vivo by Disruption of Tumor Cell Surface CD44 Function

  1997influential reference
• Interdomain binding mediates tumor growth suppression by the NF2 gene product

  1997influential reference
• Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway

  1996influential reference
• Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.

  1996cited by this paper
• Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.

  1996cited by this paper
• Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.

  1996cited by this paper
• Screening for germ‐line mutations in the NF2 Gene

  1995cited by this paper
• The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells.

  1995cited by this paper
• Molecular cloning and characterization of alternatively spliced transcripts of the mouse neurofibromatosis 2 gene.

  1994cited by this paper
• Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression.

  1994cited by this paper
• Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types

  1994cited by this paper
• ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons

  1994influential reference
• New insights into the neurofibromatoses.

  1994cited by this paper
• CD44 and its interaction with extracellular matrix.

  1993cited by this paper
• A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

  1993cited by this paper
• The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat.

  1993cited by this paper
• Synaptic transmission: a bidirectional and self-modifiable form of cell-cell communication.

  1993cited by this paper
• Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker

  1993cited by this paper
• Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

  1993cited by this paper
• A clinical study of type 2 neurofibromatosis.

  1992cited by this paper
• Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

  1992cited by this paper
• A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

  1991cited by this paper
• CD44 is the principal cell surface receptor for hyaluronate.

  1990cited by this paper
• A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family.

  1989cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper

• Signalling pathways regulated by FSTL1 in inflammation and potential therapeutic applications (Review)

  2026cites this paper
• Layilin inhibits integrin activation, and its loss results in platelet hyperactivation via Rac1 in inflammatory bowel disease.

  2025cites this paper
• Current molecular understanding of central nervous system schwannomas

  2025cites this paper
• CD44 Variant Expression in Follicular Cell-Derived Thyroid Cancers: Implications for Overcoming Multidrug Resistance

  2025cites this paper
• CD44 as a Central Integrator of Inflammation and Fibrosis: From Molecular Signaling to Environmental Modulation

  2025cites this paper
• Cancer stem cell markers: Symphonic masters of chemoresistance and immune evasion.

  2024cites this paper
• CD44 and RHAMM Are Microenvironmental Sensors with Dual Metastasis Promoter and Suppressor Functions

  2024cites this paper
• CD44: a cancer stem cell marker and therapeutic target in leukemia treatment

  2024cites this paper
• NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity

  2024cites this paper
• Impaired instructive and protective barrier functions of the endothelial cell glycocalyx pericellular matrix is impacted in COVID‐19 disease

  2024cites this paper
• A Narrative Review on CD44’s Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence

  2023cites this paper
• The Future of Vestibular Schwannoma Management.

  2023cites this paper
• Deletion of Cd44 Inhibits Metastasis Formation of Liver Cancer in Nf2-Mutant Mice

  2023cites this paper
• The genetic landscape and possible therapeutics of neurofibromatosis type 2

  2023cites this paper
• Hyaluronan hydrates and compartmentalises the CNS/PNS extracellular matrix and provides niche environments conducive to the optimisation of neuronal activity

  2023cites this paper
• Delineating the glioblastoma stemness by genes involved in cytoskeletal rearrangements and metabolic alterations

  2023cites this paper
• Hyaluronan network: a driving force in cancer progression.

  2022cites this paper
• Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

  2022cites this paper
• Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP

  2022cites this paper
• CD44 In Sarcomas: A Comprehensive Review and Future Perspectives

  2022cites this paper
• Potential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects

  2021cites this paper
• Cluster of differentiation 44 promotes osteosarcoma progression in mice lacking the tumor suppressor Merlin

  2020cites this paper
• Tumour stem cells in schwannoma: A review.

  2019cites this paper
• TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer

  2019cites this paper
• Identification of Predictive Proteins and Biological Pathways for the Tumorigenicity of Vestibular Schwannoma by Proteomic Profiling

  2019cites this paper
• Molecular mechanisms underlying the functions of cellular markers associated with the phenotype of Cancer Stem Cells.

  2018cites this paper
• Receptor‐Targeted Drug Delivery and the (Many) Problems We Know of: The Case of CD44 and Hyaluronic Acid

  2018cites this paper
• Immunohistochemical evaluation of CD44 expression in mucoepidermoid carcinoma of human salivary glands

  2018influential citation
• Cerebrospinal Fluid Hyaluronan and Neurofibromatosis Type 2

  2018cites this paper
• The Hippo signaling pathway: an emerging anti-cancer drug target.

  2017cites this paper
• Inflammation and Cancer

  2017cites this paper
• Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.

  2017cites this paper
• Hippo pathway - brief overview of its relevance in cancer.

  2017cites this paper
• The role of CD44 in glioblastoma multiforme.

  2016cites this paper
• FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases

  2016cites this paper
• Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent.

  2016cites this paper
• Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer

  2016cites this paper
• Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer

  2015cites this paper
• Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target

  2015cites this paper
• Tumor Biology of Vestibular Schwannoma: A Review of Experimental Data on the Determinants of Tumor Genesis and Growth Characteristics

  2015cites this paper
• The Hippo pathway in chemotherapeutic drug resistance

  2015cites this paper
• Cancer Stem Cells Concise Review : Emerging Role of CD 44 in Cancer Stem Cells : A Promising Biomarker and Therapeutic Target

  2015cites this paper
• Hyaluronic Acid and Its Receptors in the Mechanobiology of Gliomblastoma Multiforme

  2015cites this paper
• Patterns of protein expression and cytogenetic alterations in meningiomas: relationship with the clinical and biological features of the disease

  2015influential citation
• Role of Merlin/NF2 Inactivation in Tumor Biology

  2015cites this paper
• Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer

  2015cites this paper
• Schwannomas and Their Pathogenesis

  2014cites this paper
• The Role of Hyaluronic Acid and Its Receptors in the Growth and Invasion of Brain Tumors

  2014cites this paper
• Tumor suppressor role of protein 4.1B/DAL-1

  2014cites this paper
• CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signals.

  2014cites this paper
• Functional interdependence of NHE1 and merlin in human melanoma cells.

  2014cites this paper
• DNA copy gains of tumor-related genes in vestibular schwannoma

  2013cites this paper
• Physics of cell adhesion :

  2013cites this paper
• Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2

  2013cites this paper
• Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells

  2013cites this paper
• Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms

  2012influential citation
• Merlin Is a Negative Regulator of Human Melanoma Growth

  2012cites this paper
• Lack of Neurofibromatosis Type 2 Gene Promoter Methylation in Sporadic Vestibular Schwannomas

  2012cites this paper
• In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147

  2012cites this paper
• AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer

  2012cites this paper
• Merlin: the wizard requires protein stability to function as a tumor suppressor.

  2012cites this paper
• 28 – Acoustic neurinoma (vestibular schwannoma)

  2012cites this paper
• Merlin; NF2 Tumor Suppressor and Regulator of Receptor Distribution/Signaling

  2011cites this paper
• CD44s and CD44v6 Are Predominantly Expressed in the Non-germinal Center B-Cell-like Type of Diffuse Large B-Cell Lymphomas

  2011cites this paper
• CD 44 s and CD 44 v 6 Are Predominantly Expressed in the Non-germinal Center B-Cell-like Type of Diffuse Large B-Cell Lymphomas

  2011cites this paper
• Attending persistent T cell activation in alopecia areata : A therapeutic option

  2011cites this paper
• Structure and function analysis of the Merlin Sip1 complex

  2011cites this paper
• Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation

  2011cites this paper
• Loss of Tumor Suppressor Merlin in Advanced Breast Cancer Is due to Post-translational Regulation*

  2011cites this paper
• Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.

  2011cites this paper
• The molecular biology and novel treatments of vestibular schwannomas.

  2011cites this paper
• The influence of hyaluronic acid on vascular endothelial cell proliferation and the relationship with ezrin/merlin expression.

  2011cites this paper
• CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.

  2010cites this paper
• Moulding the shape of a metastatic cell.

  2010cites this paper
• Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.

  2010cites this paper
• Merlin Knockdown in Human Schwann Cells: Clues to Vestibular Schwannoma Tumorigenesis

  2010cites this paper
• Phenyl-methylene hydantoins alter CD44-specific ligand binding of benign and malignant prostate cells and suppress CD44 isoform expression.

  2010cites this paper
• Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity

  2010cites this paper
• CpG island hypermethylation of the neurofibromatosis type 2 (NF2) gene is rare in sporadic vestibular schwannomas

  2010cites this paper
• Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.

  2010cites this paper
• Angiopoietin-4 Promotes Glioblastoma Progression by Enhancing Tumor Cell Viability and Angiogenesis

  2010cites this paper
• Pleiotropic function of ezrin in human metastatic melanomas

  2009cites this paper
• CD44 Meets Merlin and Ezrin: Their Interplay Mediates the Pro-Tumor Activity of CD44 and Tumor-Suppressing Effect of Merlin

  2009cites this paper
• Functional Aspects of the Hyaluronan and Chondroitin Sulfate Receptors

  2009cites this paper
• The merlin interacting proteins reveal multiple targets for NF2 therapy.

  2008cites this paper
• Novel Molecular Interactions and Biological Functions of the Neurofibromatosis 2 Tumor Suppressor Protein, Merlin

  2008cites this paper
• Compensative Shuttling of Merlin to Phosphorylation on Serine 518 in Vestibular Schwannoma

  2008cites this paper
• Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton

  2008cites this paper
• The Neurofibromatosis 2 Protein, Merlin, Regulates Glial Cell Growth in an ErbB2- and Src-Dependent Manner

  2008influential citation
• Merlin is a potent inhibitor of glioma growth.

  2008cites this paper
• Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells

  2008cites this paper
• The CD44 standard/ezrin complex regulates Fas-mediated apoptosis in Jurkat cells

  2007cites this paper
• Molecular studies of vestibular schwannomas: a review

  2007cites this paper
• Overexpression of Merlin in B16F10 mouse melanoma cells reduces their metastatic activity: role of the cell surface heparan sulfate glycosaminoglycans.

  1992cites this paper